Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Titer”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Study completedNCT01022749
What this trial is testing

Efficacy Safety Study of Flu Vaccine in Immunodepression Patients

Who this might be right for
Inflammatory Bowel Disease (IBD)
Assistance Publique - Hôpitaux de Paris 228
Not applicableLooking for participantsNCT05384509
What this trial is testing

(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies

Who this might be right for
Cancer
Chang Gung Memorial Hospital 320
Large-scale testing (Phase 3)Study completedNCT06177249
What this trial is testing

To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

Who this might be right for
Rabies Human
Hualan Biological Bacterin Co. Ltd. 1,956
Testing effectiveness (Phase 2)Study completedNCT00068055
What this trial is testing

IVIG - West Nile Encephalitis: Safety and Efficacy

Who this might be right for
West Nile Virus
National Institute of Allergy and Infectious Diseases (NIAID) 62
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Large-scale testing (Phase 3)Ended earlyNCT01445197
What this trial is testing

Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development

Who this might be right for
Hemophilia A
CSL Behring 1
Not applicableStudy completedNCT04360278
What this trial is testing

Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19

Who this might be right for
COVID-19
National Institutes of Health Clinical Center (CC) 258
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Large-scale testing (Phase 3)Ended earlyNCT04361253
What this trial is testing

Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy

Who this might be right for
COVIDInfectious Disease
Brigham and Women's Hospital 45
Not applicableUnknownNCT01742728
What this trial is testing

Nagasaki and Tokushima

Who this might be right for
Periodontitis
University of Tokushima 2,000
Not applicableUnknownNCT02219061
What this trial is testing

Early Waning of Maternal Measles and Meningitis C Antibodies

Who this might be right for
Measles
Guangzhou Center for Disease Control and Prevention 100
Post-approval studies (Phase 4)Study completedNCT01700621
What this trial is testing

Coadministration of Measles-rubella and Rotavirus Vaccines

Who this might be right for
Measles Antibody SeroconversionRubella Antibody SeroconversionRotavirus Geometric Mean Titer (GMT)+1 more
PATH 482
Testing effectiveness (Phase 2)Study completedNCT03719066
What this trial is testing

Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

Who this might be right for
Adverse Reaction to Cholera VaccineCholera Vaccination Reaction
Johns Hopkins Bloomberg School of Public Health 181
Not applicableStudy completedNCT02338986
What this trial is testing

Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases

Who this might be right for
Communicable DiseasesCommunicable Diseases, EmergingEmerging Infectious Diseases+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableUnknownNCT04387929
What this trial is testing

Detection of Anti-COVID-19 Antibody Levels in an Hospital Population

Who this might be right for
COVID-19
Istituto Clinico Humanitas 6,000
Not applicableStudy completedNCT00264784
What this trial is testing

GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine

Who this might be right for
Streptococcus Group A
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Looking for participantsNCT06747312
What this trial is testing

Effect of Belimumab on Antibody Titers in Primary APS Patients

Who this might be right for
Antiphospholipid Syndrome (APS)
Ruijin Hospital 20
Not applicableEnrolling By InvitationNCT02511002
What this trial is testing

Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge

Who this might be right for
Post Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT05104359
What this trial is testing

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Who this might be right for
COVID-19COVID-19 VaccinesImmunogenicity, Vaccine
Epividian 825
Testing effectiveness (Phase 2)Study completedNCT00069316
What this trial is testing

Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease

Who this might be right for
West Nile Virus
National Institutes of Health Clinical Center (CC) 2
Load More Results